ADARX Pharmaceuticals
United States · $321.0M raised
- Business Model
- B2B
- Website
- adarx.com
- Total Funding
- $321.0M
- Last Round
- $200.0M Series CAug 2023
About
Clinical-stage biotechnology company developing next-generation RNA therapeutics to treat a broad spectrum of diseases.
Summary
ADARX Pharmaceuticals is a Biotech company based in United States. It has raised $321.0M in total, most recently a $200.0M Series C round in Aug 2023.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Funding History
No funding data available yet.
Know something? Help us improve our data.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...